mhurhangee/patent-ind-claim-en huggingface dataset:
A micro device (MD), arranged for implantation into biological tissue, the micro device (MD) comprising - a piezoelectric transducer (PZC), - a power management circuit (PMC) connected to the piezoelectric transducer, and being arranged to generate an electric power output (PW) for powering components of the micro device (MD) in response to an ultrasonic power signal (UPW) received by the piezoelectric transducer (PZC) from an external source, - a sensor (SNS) arranged to measure a physical parameter or a neural activity (LFP), and to generate an electric signal accordingly, - an electric circuit (FE) arranged to receive the electric signal from the sensor, and to digitize the electric signal by means of time-encoding analog-to-digital converter (D1B), to generate a one-bit data stream representing the electric signal from the sensor, and - a load modulation circuit (LMC) comprising at least one electric switch (M3, M4) connected to terminals of the piezoelectric transducer (PZC), so as to allow modulation of electric load of the piezoelectric transducer (PZC) in response to the one-bit data stream, so that a backscattered signal (B_U) from the piezoelectric transducer (PZC) is modulated by the one-bit data stream, characterized in that the micro device (MD) is arranged to store a time sequence of the generated one-bit data stream in a memory, and applying the stored time sequence of the one-bit data stream to the load modulation circuit at an increased data rate to provide a time compression of data represented in the backscattered signal. - a piezoelectric transducer (PZC), - a power management circuit (PMC) connected to the piezoelectric transducer, and being arranged to generate an electric power output (PW) for powering components of the micro device (MD) in response to an ultrasonic power signal (UPW) received by the piezoelectric transducer (PZC) from an external source, - a sensor (SNS) arranged to measure a physical parameter or a neural activity (LFP), and to generate an electric signal accordingly, - an electric circuit (FE) arranged to receive the electric signal from the sensor, and to digitize the electric signal by means of time-encoding analog-to-digital converter (D1B), to generate a one-bit data stream representing the electric signal from the sensor, and - a load modulation circuit (LMC) comprising at least one electric switch (M3, M4) connected to terminals of the piezoelectric transducer (PZC), so as to allow modulation of electric load of the piezoelectric transducer (PZC) in response to the one-bit data stream, so that a backscattered signal (B_U) from the piezoelectric transducer (PZC) is modulated by the one-bit data stream,
A diaphragm assembly for a control regulator , the diaphragm assembly comprising: a diaphragm including an elastomer upper layer , a fabric middle layer , and an elastomer lower layer ; a pressure relief mechanism ; and a diaphragm plate that supports the diaphragm ; the pressure relief mechanism comprising an opening in the diaphragm middle layer and an opening in the diaphragm plate ; wherein the openings are aligned and form a locally weakened area in the diaphragm, whereby the material of the diaphragm upper layer and the material of the diaphragm lower layer are not supported or reinforced by the material in the diaphragm middle layer . a diaphragm including an elastomer upper layer , a fabric middle layer , and an elastomer lower layer ; a pressure relief mechanism ; and a diaphragm plate that supports the diaphragm ; the pressure relief mechanism comprising an opening in the diaphragm middle layer and an opening in the diaphragm plate ; wherein the openings are aligned and form a locally weakened area in the diaphragm, whereby the material of the diaphragm upper layer and the material of the diaphragm lower layer are not supported or reinforced by the material in the diaphragm middle layer .
Device for coating containers by means of a coating process with a support frame , the external dimensions of which are smaller than the internal dimensions of an ISO container, into which the device for transport can be inserted, wherein the following areas are available within the support frame : - a conveying area in which at least one conveying device for the containers is arranged, - a treatment area is available in which at least one container treatment unit for coating the containers is arranged, - a transfer area in which a transfer device is arranged that moves the containers between the conveying device and the container treatment unit, - a maintenance area which is easily accessible from the outside, which is arranged on the rear side of at least one container treatment unit, - an electronics area in which a control cabinet for the electronics of the components of the device is arranged, - a process gas treatment area in which the components for handling the process gas for the coating process are arranged, - a vacuum pump area in which vacuum pumps are arranged to generate the vacuum required for the coating process. - a conveying area in which at least one conveying device for the containers is arranged, - a treatment area is available in which at least one container treatment unit for coating the containers is arranged, - a transfer area in which a transfer device is arranged that moves the containers between the conveying device and the container treatment unit, - a maintenance area which is easily accessible from the outside, which is arranged on the rear side of at least one container treatment unit, - an electronics area in which a control cabinet for the electronics of the components of the device is arranged, - a process gas treatment area in which the components for handling the process gas for the coating process are arranged, - a vacuum pump area in which vacuum pumps are arranged to generate the vacuum required for the coating process.
An orthopedic pillow for treatment of lumbar and thoracic spine diseases comprising: a padded member and a hard block fully inserted inside the padded member ; the padded member is made of resilient materials such as foam, rubber, or cotton; the padded member 's shape is almost similar to that of a rectangular block; and if looked from its right or left side, the padded member has a bell shape whose bottom is broader than the top to ensure stability; the length of the long side of the padded member is roughly equal to an adult's body's width; the shape of the hard block and of the padded member are similar, and their dimensions are proportional; the hard block is made of non-resilient material, such as wood, polystyrene foam, or hard rubber; the hard block is able to tolerate, without rupturing, the gravity force on a mass of about 140 kg with a shape and size similar to those of a person's body; the length of the long side of the hard block is also roughly equal to an adult's body's width; and both the padded member and the hard block have a flat bottom side. the padded member is made of resilient materials such as foam, rubber, or cotton; the padded member 's shape is almost similar to that of a rectangular block; and if looked from its right or left side, the padded member has a bell shape whose bottom is broader than the top to ensure stability; the length of the long side of the padded member is roughly equal to an adult's body's width; the shape of the hard block and of the padded member are similar, and their dimensions are proportional; the hard block is made of non-resilient material, such as wood, polystyrene foam, or hard rubber; the hard block is able to tolerate, without rupturing, the gravity force on a mass of about 140 kg with a shape and size similar to those of a person's body; the length of the long side of the hard block is also roughly equal to an adult's body's width; and both the padded member and the hard block have a flat bottom side.
A wireless device for handling wake-up signaling, wherein the wireless device comprises: radio circuitry ; interface circuitry configured to: receive a wake-up signal comprising wake-up information and authentication information; and determine whether the wake-up signal is intended for the wireless device based on the wake-up information; and processing circuitry configured to: determine whether the wake-up signal is authentic based on the authentication information; wherein, upon determining that the wake-up signal is intended for the wireless device , the interface circuitry is further configured to initiate wake-up of the processing circuitry before forwarding the authentication information to the processing circuitry ; and upon determining that the wake-up signal is authentic, the processing circuitry is further configured to initiate wake-up of the radio circuitry being a radio part of a main radio chip comprised in the wireless device , wherein security mechanisms defined in a main radio protocol are used to authenticate the wake-up signal. radio circuitry ; interface circuitry configured to: receive a wake-up signal comprising wake-up information and authentication information; and determine whether the wake-up signal is intended for the wireless device based on the wake-up information; and receive a wake-up signal comprising wake-up information and authentication information; and determine whether the wake-up signal is intended for the wireless device based on the wake-up information; and processing circuitry configured to: determine whether the wake-up signal is authentic based on the authentication information; wherein, upon determining that the wake-up signal is intended for the wireless device , the interface circuitry is further configured to initiate wake-up of the processing circuitry before forwarding the authentication information to the processing circuitry ; and upon determining that the wake-up signal is authentic, the processing circuitry is further configured to initiate wake-up of the radio circuitry being a radio part of a main radio chip comprised in the wireless device , wherein security mechanisms defined in a main radio protocol are used to authenticate the wake-up signal.
A computer-implemented method for evaluating vulnerability of program code, the method comprising: receiving an intermediate result generated by a compiler based on source code , wherein the intermediate result includes one or more vulnerability indicators indicating one or more lines of the source code being potentially vulnerable; performing a grey box fuzzing process on a first executable code generated from the intermediate result to generate a first set of seed inputs; calculating a vulnerability score for each of the seed inputs of the first set based on the vulnerability indicators for the lines of the source code reachable but not explored by the grey box fuzzing process; selecting one of the seed inputs in the first set having a highest vulnerability score; and performing a concolic execution using the selected seed input as a priority, the concolic execution being performed on a second executable code generated from the intermediate result. receiving an intermediate result generated by a compiler based on source code , wherein the intermediate result includes one or more vulnerability indicators indicating one or more lines of the source code being potentially vulnerable; performing a grey box fuzzing process on a first executable code generated from the intermediate result to generate a first set of seed inputs; calculating a vulnerability score for each of the seed inputs of the first set based on the vulnerability indicators for the lines of the source code reachable but not explored by the grey box fuzzing process; selecting one of the seed inputs in the first set having a highest vulnerability score; and wherein the intermediate result includes one or more vulnerability indicators indicating one or more lines of the source code being potentially vulnerable; performing a grey box fuzzing process on a first executable code generated from the intermediate result to generate a first set of seed inputs; calculating a vulnerability score for each of the seed inputs of the first set based on the vulnerability indicators for the lines of the source code reachable but not explored by the grey box fuzzing process; selecting one of the seed inputs in the first set having a highest vulnerability score; and performing a concolic execution using the selected seed input as a priority, the concolic execution being performed on a second executable code generated from the intermediate result.
A method, performed in a network node, the method comprising: - obtaining (S1) a timing of a first control signal comprising control information; - evaluating (S2) whether a first synchronization signal associated with a previously configured second control signal can also be used to provide synchronization between a receiving wireless device and the network node at reception of the first control signal; when the evaluation (S2) is negative then, - transmitting (S3) a second synchronization signal configured to provide synchronization between the receiving wireless device and the network node at reception of the first control signal, and - transmitting (S5) the first control signal, wherein the first control signal is any one of: a tracking area signal, a paging signal and a random access response signal, and the previously configured second control signal carries system information. - obtaining (S1) a timing of a first control signal comprising control information; - evaluating (S2) whether a first synchronization signal associated with a previously configured second control signal can also be used to provide synchronization between a receiving wireless device and the network node at reception of the first control signal; when the evaluation (S2) is negative then, - transmitting (S3) a second synchronization signal configured to provide synchronization between the receiving wireless device and the network node at reception of the first control signal, and - transmitting (S5) the first control signal, wherein the first control signal is any one of: a tracking area signal, a paging signal and a random access response signal, and the previously configured second control signal carries system information.
An antibody or an antigen-binding fragment thereof which specifically binds the alpha 3 domain of a HLA-G protein and which recognizes a conformational epitope contained in an amino acid sequence having SEQ ID No. 1 and which blocks the binding of a HLA-G protein exhibiting an alpha 3 domain to at least one of leukocyte immunoglobulin-like receptor B1 (LILRB1) or leukocyte immunoglobulin-like receptor B2 (LILRB2) receptors, in particular which blocks the binding of said HLA-G protein to both LILRB1 and LILRB2 receptors.
A method for installing a liner string in a casing string disposed within a wellbore , the method comprising: positioning the liner string in the wellbore, the liner string including, at its upper end, a liner hanger and a liner top ; running the liner string through the casing string such that at least the liner hanger is positioned within the casing string; after running the liner string through the casing string, positioning a setting tool in the wellbore, the setting tool having an expansion cone assembly and a locator cylinder ; running the setting tool through the casing string until the locator cylinder contacts the liner top; axially moving the expansion cone assembly relative to the locator cylinder through the liner string to radially expand the liner hanger into contact with the casing string, thereby to seal and anchor the liner hanger to the casing string; and retrieving the setting tool out of the wellbore. positioning the liner string in the wellbore, the liner string including, at its upper end, a liner hanger and a liner top ; running the liner string through the casing string such that at least the liner hanger is positioned within the casing string; after running the liner string through the casing string, positioning a setting tool in the wellbore, the setting tool having an expansion cone assembly and a locator cylinder ; running the setting tool through the casing string until the locator cylinder contacts the liner top; axially moving the expansion cone assembly relative to the locator cylinder through the liner string to radially expand the liner hanger into contact with the casing string, thereby to seal and anchor the liner hanger to the casing string; and retrieving the setting tool out of the wellbore.
An acid alpha-glucosidase (GAA) binding protein comprising one or more GAA binding domains wherein at least one domain comprises the amino acid sequence of SEQ ID NO: 1 or of SEQ ID NO: 2, or an amino acid sequence with at least 95 % sequence identity thereto.
A transformerless uninterruptible power supply (UPS) system comprising: a neutral-point-clamped inverter with a first capacitor (C1) associated to a first voltage difference (V dc1 ) and a second capacitor (C2) associated to a second voltage difference (V dc2 ), the neutral-point-clamped inverter to supply power to a load ; characterized in a controller to control the inverter to operate in a three-level mode or higher when the load is substantially balanced, i.e., when a difference between the first voltage difference and the second voltage difference does not exceed a threshold, and to operate in a two-level mode when the load is substantially unbalanced, i.e., when the difference between the first voltage difference and the second voltage difference exceeds the threshold. a neutral-point-clamped inverter with a first capacitor (C1) associated to a first voltage difference (V dc1 ) and a second capacitor (C2) associated to a second voltage difference (V dc2 ), the neutral-point-clamped inverter to supply power to a load ; characterized in a controller to control the inverter to operate in a three-level mode or higher when the load is substantially balanced, i.e., when a difference between the first voltage difference and the second voltage difference does not exceed a threshold, and to operate in a two-level mode when the load is substantially unbalanced, i.e., when the difference between the first voltage difference and the second voltage difference exceeds the threshold.
An isolator decoupler comprising: a pulley ; a shaft ; the pulley journalled to the shaft; a spring carrier disposed within the pulley ; a torsion spring coupled between the pulley and the spring carrier ; a wrap spring one way clutch wrapped about the shaft and having a frictional engagement therewith, the wrap spring one way clutch coupled to the spring carrier ; the wrap spring one way clutch is disposed radially inward of the torsion spring ; and characterized by : the pulley comprising an engaging surface for engaging an end of the wrap spring one way clutch , wherein the engaging surface is configured to be temporarily engageable with the end of the wrap spring one way clutch in an unwinding direction, whereby a temporary contact between the wrap spring one way clutch end and the pulley unwinds the wrap spring one way clutch thereby temporarily diminishing the frictional engagement of the wrap spring one way clutch with the shaft . a pulley ; a shaft ; the pulley journalled to the shaft; a spring carrier disposed within the pulley ; a torsion spring coupled between the pulley and the spring carrier ; a wrap spring one way clutch wrapped about the shaft and having a frictional engagement therewith, the wrap spring one way clutch coupled to the spring carrier ; the wrap spring one way clutch is disposed radially inward of the torsion spring ; and characterized by : the pulley comprising an engaging surface for engaging an end of the wrap spring one way clutch , wherein the engaging surface is configured to be temporarily engageable with the end of the wrap spring one way clutch in an unwinding direction, whereby a temporary contact between the wrap spring one way clutch end and the pulley unwinds the wrap spring one way clutch thereby temporarily diminishing the frictional engagement of the wrap spring one way clutch with the shaft .
A method of evaluating drug resistance in hormone therapy, comprising: measuring a primary level of TRBP in a sample obtained from a subject before treatment with tamoxifen;: measuring a level of TRBP in a sample obtained from the subject after an effective amount of tamoxifen, an active form of tamoxifen or an analogous of tamoxifen had been administered to the subject; and discriminating tamoxifen resistance through a level change of TRBP in the subject. measuring a primary level of TRBP in a sample obtained from a subject before treatment with tamoxifen;: measuring a level of TRBP in a sample obtained from the subject after an effective amount of tamoxifen, an active form of tamoxifen or an analogous of tamoxifen had been administered to the subject; and discriminating tamoxifen resistance through a level change of TRBP in the subject.
A compound of Formula (IA): or a pharmaceutically acceptable salt thereof, wherein, R g is hydrogen or C 1-3 alkyl; and R h and R f are independently hydrogen or C 1-3 alkyl. or a pharmaceutically acceptable salt thereof, wherein, R g is hydrogen or C 1-3 alkyl; and R h and R f are independently hydrogen or C 1-3 alkyl.
A pharmaceutical composition comprising a cyclohexenone compound having the structure: for use in treating or reducing the symptoms of atopic dermatitis in a subject, wherein each of X and Y independently is oxygen, NR 5 or sulfur; R is a hydrogen or C(=O)C 1 -C 8 alkyl; each of R 1 , R 2 and R 3 independently is a hydrogen, optionally substituted methyl or (CH 2 ) m -CH 3 ; R 4 is NR 5 R 6 , OR 5 , OC(=O)R 7 , C(=O)OR 5 , C(=O)R 5 , C(=O)NR 5 R 6 , halogen, 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, glucosyl, wherein the 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, and glucosyl are optionally substituted with one or more substituents selected from NR 5 R 6 , OR 5 , OC(=O)R 7 , C(=O)OR 5 , C(=O)R 5 , C(=O)NR 5 R 6 , C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, and C 1 -C 8 haloalkyl; each of R 5 and R 6 is independently a hydrogen or C 1 -C 8 alkyl; R 7 is a C 1 -C 8 alkyl, OR 5 or NR 5 R 6 ; m = 1-12; and n=1-12; or a pharmaceutically acceptable salt, or solvate thereof. R is a hydrogen or C(=O)C 1 -C 8 alkyl; each of R 1 , R 2 and R 3 independently is a hydrogen, optionally substituted methyl or (CH 2 ) m -CH 3 ; R 4 is NR 5 R 6 , OR 5 , OC(=O)R 7 , C(=O)OR 5 , C(=O)R 5 , C(=O)NR 5 R 6 , halogen, 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, glucosyl, wherein the 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, and glucosyl are optionally substituted with one or more substituents selected from NR 5 R 6 , OR 5 , OC(=O)R 7 , C(=O)OR 5 , C(=O)R 5 , C(=O)NR 5 R 6 , C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, and C 1 -C 8 haloalkyl; each of R 5 and R 6 is independently a hydrogen or C 1 -C 8 alkyl; R 7 is a C 1 -C 8 alkyl, OR 5 or NR 5 R 6 ; m = 1-12; and n=1-12; or a pharmaceutically acceptable salt, or solvate thereof.